PLASMA LH AND FSH RESPONSE TO LRH AND PLASMA TESTOSTERONE LEVELS IN BOYS WITH IRREGULAR PUBERTY

1977 ◽  
Vol 85 (3) ◽  
pp. 456-464 ◽  
Author(s):  
Zvi Dickerman ◽  
Yehuda Bar-Haim ◽  
Ruth Prager-Lewin ◽  
Haiuta Kaufman ◽  
Zvi Laron
Keyword(s):  
Bone Age ◽  
Pubic Hair ◽  
Growth Spurt ◽  
Plasma Testosterone ◽  
Control Group ◽  
Testicular Development ◽  
Pubertal Stage ◽  
Testosterone Levels ◽  
Basal Plasma ◽  
Pubertal Stages

ABSTRACT Nineteen boys with irregular puberty (IP), defined as a discrepancy of two or more pubertal stages between the criteria for genitalia and that for pubic hair, were subjected to a standard LRH test (50 μg/m2, iv) and the response of gonadotrophins as well as the basal levels of plasma testosterone, LH and FSH were compared to those of boys with normal, regular puberty. When the results were plotted against the pubertal stage for genitalia (Pg), it was found that in the boys with IP the basal plasma testosterone levels were lower and the response of plasma LH to LRH stimulation lesser than in the controls. However, when these parameters were plotted against the pubertal stage for pubic hair (Ph) it was found, that in the boys with IP the plasma testosterone levels were significantly higher and the response of both LH and FSH stimulation greater than in the control group. It was concluded that irregular puberty in boys may be regarded as a normal variation. The delayed development of sexual hair and penile length, and retarded pubertal growth spurt and bone age maturation seen in these boys, with normal testicular development, may be explained by a temporary reduced peripheral sensitivity to androgens and a compensatory effort by the pituitary, manifested in increased secretion of LH and testosterone, relatively to their pubertal stage for pubic hair.

PLASMA TESTOSTERONE IN MALE PUBERTY

1974 ◽  
Vol 75 (1) ◽  
pp. 181-194 ◽  
Author(s):  
D. Knorr ◽  
F. Bidlingmaier ◽  
O. Butenandt ◽  
H. Fendel ◽  
R. Ehrt-Wehle
Keyword(s):  
Bone Age ◽  
Pubic Hair ◽  
Cross Sectional Study ◽  
Growth Spurt ◽  
Plasma Testosterone ◽  
Gas Liquid Chromatography ◽  
Cross Sectional ◽  
Sexual Characteristics ◽  
Testicular Size ◽  
Axillary Hair

ABSTRACT Plasma testosterone was investigated by gas-liquid chromatography with an electron capture detector in a cross-sectional study in childhood and during puberty in 214 boys. The testosterone values were correlated with sexual characteristics such as axillary hair, pubic hair, testicular size and bone age. In 22 individuals during puberty a longitudinal study was started, indicating a very steep increase of plasma testosterone between 40 and 240 ng/100 ml. This stage is mostly passed through very rapidly within 10 months. Plasma testosterone, growth velocity and weight gain were correlated in two boys during puberty. The peak of growth spurt occurs between 50 and 170 ng of plasma testosterone.

INFLUENCE OF METYRAPONE ON PLASMA CONCENTRATIONS OF TESTOSTERONE AND ANDROSTENEDIONE IN MAN

1971 ◽  
Vol 68 (3) ◽  
pp. 576-584 ◽  
Author(s):  
K. O. Nilsson ◽  
B. Hökfelt
Keyword(s):  
Body Weight ◽  
Male Patient ◽  
Gradual Increase ◽  
Plasma Concentrations ◽  
Plasma Testosterone ◽  
Testosterone Levels ◽  
Basal Plasma ◽  
Normal Males ◽  
A Minor ◽  
Secondary Hypogonadism

ABSTRACT Metyrapone was administered either orally, 750 mg every four h, in a total of six doses, or intravenously 30 mg per kg body weight as a four h infusion. In three males with normal endocrine functions, metyrapone given orally or intravenously induced a fall in plasma testosterone and an elevation of androstenedione within 2–8 h. When metyrapone was administered to a patient given dexamethasone to suppress endogenous ACTH production, the androstenedione levels did not alter whereas the testosterone levels showed a slight, transient decrease. In two normal females metyrapone administration was followed by a marked increase in plasma androstenedione whereas testosterone showed only a minor, gradual increase. In one male patient with Addison's disease the basal plasma testosterone was normal whereas the level of androstenedione was low. Following metyrapone intravenously, there was a slight suppression of plasma testosterone but no change in the androstenedione concentration. In one patient with primary hypogonadism, two with secondary hypogonadism and two with Klinefelter's syndrome the plasma testosterone was low under basal conditions and did not change following metyrapone. Basal plasma androstenedione was within the range for normal males and increased markedly following metyrapone in all the cases.

Effects of oestradiol benzoate (OeB) and human chorionic gonadotrophin (hCG) on the testes and accessory sex glands of the rat

1981 ◽  
Vol 96 (2) ◽  
pp. 273-280 ◽  
Author(s):  
Mridula Chowdhury ◽  
Robert Tcholakian ◽  
Emil Steinberger
Keyword(s):  
Treated Group ◽  
Inhibitory Effect ◽  
Male Rats ◽  
Plasma Testosterone ◽  
Control Group ◽  
Intact Male ◽  
Intact Control ◽  
Testosterone Levels ◽  
Oestradiol Benzoate ◽  
Direct Inhibitory Effect

Abstract. It has been suggested that treatment of intact male rats with oestradiol benzoate (OeB) causes an interference with testosterone (T) production by the testes by a direct inhibitory effect on steroidogenesis. To test this hypothesis, different doses (5, 10 or 25 IU) of hCG were administered concomitantly with 50 μg of OeB to adult intact or hypophysectomized male rats. The testicular and plasma testosterone, and serum hCG levels were determined. The sex accessory weights were recorded. In the intact OeB-treated group of animals, hCG stimulated both the secondary sex organs and plasma testosterone levels above the intact control group. However, in hypophysectomized animals, although plasma testosterone levels increased above that of intact controls, their secondary sex organ weights did not. Moreover, inspite of high circulating hCG levels, the testicular testosterone content and concentration remained suppressed in OeB-treated animals. The reason for such dichotomy of hCG action on OeB-treated animals is not clear at present.

scholarly journals Peripheral Administration of RF9 Does Not Affect Hypothalamic-PituitaryGonadal Axis in Normal Fed Adult Male Macaque

2020 ◽  
pp. 1-5
Author(s):  
Aalia Batool ◽  
Madiha Wazir ◽  
Rahim Ullah ◽  
Aalia Batool ◽  
Rabia Naz ◽  
...  
Keyword(s):  
Adult Male ◽  
Normal Saline ◽  
Time Windows ◽  
Treated Group ◽  
Plasma Testosterone ◽  
Control Group ◽  
Hpg Axis ◽  
Testosterone Levels ◽  
Physiological Conditions ◽  
Short Time

Stress represses hypothalamic-pituitary-gonadal axis (HPG-axis) but RF9, a synthetic peptide, rescues such repression. To assess the role of RF9 in regulating HPG-axis under normal physiological conditions in higher primates, RF9 was administered to intact adult male rhesus monkeys and response of the HPG-axis was examined by measuring plasma testosterone as an end parameter of the axis. Control group (n=4) received normal saline whereas the treated group (n=4) received RF9. On the first day of experiment, four bolus injections of normal saline (1ml/animal) were administered intravenously at 2-hr interval to the control monkeys. Similarly, on the second day of experiment, treated group received four iv bolus injections of RF9 (0.1mg/kg BW) at 2-hr interval. Serial blood samples were collected at 20 min interval during a 6-hr period which started just after first saline/RF9 injection. Plasma testosterone levels were measured by using a specific EIA. Overall means of plasma testosterone levels and plasma testosterone area under curve (AUC) and overall mean testosterone and mean testosterone AUC in short time windows following each injection of RF9 and saline were comparable between the groups. Our results demonstrate that RF9 has no role in regulating HPG-axis under normal physiological conditions in adult male monkeys.

THE EFFECT OF SHORT AND LONG TERM HUMAN CHORIONIC GONADOTROPHIN (HCG) ADMINISTRATION ON PLASMA TESTOSTERONE LEVELS IN KLINEFELTER'S SYNDROME

1974 ◽  
Vol 77 (4) ◽  
pp. 753-764 ◽  
Author(s):  
A. G. H. Smals ◽  
P. W. C. Kloppenborg ◽  
Th. J. Benraad
Keyword(s):  
Plasma Testosterone ◽  
Klinefelter’S Syndrome ◽  
Klinefelter's Syndrome ◽  
Absolute Increase ◽  
Testosterone Levels ◽  
Basal Plasma ◽  
Patient Groups ◽  
Pre Treatment ◽  
Secondary Hypogonadism

ABSTRACT The effect of acute (1500 IU/day for 3 days) and chronic HCG administration (1500 IU, 3 times weekly) on plasma testosterone levels in patients with Klinefelter's syndrome was compared with the response observed in patients with hypogonadotrophic eunuchoidism and in eugonadal male controls. Basal plasma testosterone levels in the Klinefelter patients were significantly lower than in the control subjects and significantly higher than in the patients with secondary hypogonadism. In all but one Klinefelter patient the plasma LH levels were markedly elevated even in the presence of normal testosterone levels. No significant correlation could be demonstrated between the plasma testosterone concentrations and the LH levels in the Klinefelter patients. Short term HCG administration resulted in a significant increase in the plasma testosterone levels in each of the 3 groups studied, independent of the basal value. The absolute increase in the Klinefelter patients was quantitatively comparable to that in the patients with secondary hypogonadism, but significantly lower than in the eugonadal controls. During long term HCG treatment the plasma testosterone levels definitely increased in both patient groups, but remarkably in the Klinefelter patients testosterone levels tended to decrease on continuing treatment, though in most patients testosterone levels remained higher than the pre-treatment values. The data on the effect of acute and chronic HCG administration on plasma testosterone levels in this study illustrate again that Leydig cells in Klinefelter's syndrome still retain a functional reserve, though less than in eugonadal males.

Hypothalamic-Pituitary Axis Dysfunction in Survivors of Childhood CNS Tumors: Importance of Systematic Follow-Up and Early Endocrine Consultation

2016 ◽  
Vol 34 (36) ◽  
pp. 4315-4319 ◽  
Author(s):  
Wassim Chemaitilly ◽  
Gregory T. Armstrong ◽  
Amar Gajjar ◽  
Melissa M. Hudson
Keyword(s):  
Relevant Literature ◽  
Pubic Hair ◽  
Hormone Deficiency ◽  
Shunt Revision ◽  
Plasma Testosterone ◽  
Low Grade ◽  
Pubertal Stage ◽  
Suprasellar Region ◽  
Hypothalamic Pituitary Axis

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors’ suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. An 11-year-old male with a history of metastatic tectal plate low-grade glioma who was diagnosed at age 2.8 years transferred his care to the long-term follow-up clinic. He completed treatment with multiagent chemotherapy—carboplatin, vincristine, temozolomide, procarbazine, lomustine, and thioguanine—at age 4.5 years and did not require radiotherapy. At primary diagnosis, he presented with hydrocephalus that required ventriculoperitoneal shunt placement, with a subsequent shunt revision at age 6 years. Residual metastatic tumors in the third and fourth ventricles and in the suprasellar region remained stable for more than 5 years. The patient achieved normal developmental milestones and was not taking medications. He was offered screening for hypothalamic-pituitary axis (HPA) dysfunction because of his suprasellar lesion. His height was at the 25th percentile for chronological age, with decline from the 50th percentile noted during the preceding 18 months ( Fig 1 , point c). Pubertal stage was Tanner 4 for pubic hair and penile size, which contrasted with small testes (4.5 mL). Pubic hair and voice changes were noticed 2 to 3 years before this visit. Plasma testosterone level was consistent with Tanner 4 (255 ng/dL = 8.9 nmol/L). An x-ray of the left hand revealed a notably advanced bone age of 15.5 years. Plasma free T4, thyroid-stimulating hormone (TSH), and 8 am cortisol levels were normal. The patient was referred to the endocrinology clinic where he was diagnosed with growth hormone deficiency and was started on replacement therapy. He reached his final adult height of 144.1 cm at age 13.3 years ( Fig 1 , point d).

Salivary Testosterone Levels and Major Depressive Illness in Men

1992 ◽  
Vol 161 (5) ◽  
pp. 629-632 ◽  
Author(s):  
R. Huw Davies ◽  
Brian Harris ◽  
D. Roger Thomas ◽  
Nigel Cook ◽  
Graham Read ◽  
...  
Keyword(s):  
Depressive Illness ◽  
Plasma Testosterone ◽  
Control Group ◽  
Major Depressive ◽  
Salivary Testosterone ◽  
Testosterone Levels ◽  
Suppression Test ◽  
Depression Scales ◽  
Dexamethasone Suppression ◽  
Depression Ratings

Studies of testosterone levels in patients with major depressive illness have produced varying results, plasma levels usually being reported. Saliva levels reflect ‘free’ plasma testosterone, and a pilot study of 11 men with major depression with melancholia, who underwent a standard dexamethasone suppression test, is described. There were no significant differences in testosterone levels compared with an age-matched control group. In the patient group, pre-dexamethasone levels correlated significantly and negatively with depression ratings on the 21–item Hamilton and the Montgomery and åsberg depression scales, and also with state anxiety measured on the Spielberger scale.

BODY PROPORTIONS AND ANDROGENICITY IN RELATION TO PLASMA TESTOSTERONE LEVELS IN KLINEFELTER'S SYNDROME

1974 ◽  
Vol 77 (2) ◽  
pp. 387-400 ◽  
Author(s):  
A. G. H. Smals ◽  
P. W. C. Kloppenborg ◽  
T. J. Benraad
Keyword(s):  
Upper Body ◽  
Clinical State ◽  
Plasma Testosterone ◽  
Klinefelter’S Syndrome ◽  
Body Segment ◽  
Klinefelter's Syndrome ◽  
Testosterone Levels ◽  
Arm Span ◽  
Basal Plasma ◽  
Low Testosterone

ABSTRACT Basal plasma testosterone levels (mean ± sd 290 ± 141 ng/100 ml) (range 72–684 ng/100 ml) in 25 chromatin positive patients with Klinefelter's syndrome (23 XXY, 1 XXYY, 1 XY/XXY) were significantly lower than in 25 age matched controls (mean ± sd 603 ± 169 ng/100 ml). In 11 out of the 25 Klinefelter patients however, plasma testosterone levels were in the normal range and these patients differed significantly from the patients with low testosterone levels with respect to the clinical state of androgenicity. In the group of Klinefelter patients, but not in the controls, a significant negative correlationship was found between plasma testosterone levels and each of the variables: body weight, arm span, length of the lower body segment and the ratio's lower/upper and span/upper body segment.

Possible role of prolactin in the inhibitory effect of testosterone on the hypothalamic-pituitary-testicular axis in the rat

1985 ◽  
Vol 105 (3) ◽  
pp. 423-427 ◽  
Author(s):  
J. A. F. Tresguerres ◽  
L. F. Perez Mendez ◽  
A. Lopez-Calderon ◽  
A. I. Esquifino
Keyword(s):  
Inhibitory Effect ◽  
Plasma Testosterone ◽  
Plasma Prolactin ◽  
Intact Male ◽  
Testosterone Levels ◽  
Basal Plasma ◽  
Male Wistar Rats ◽  
Lh Releasing Hormone ◽  
Acute And Chronic Treatments

ABSTRACT To study the role of testosterone on the regulation of the hypothalamic-pituitary-testicular axis, young intact male Wistar rats were given acute (24 h) or chronic (5 days) subcutaneous treatments of 500 μg testosterone propionate (TP) or vehicle alone. Plasma LH, prolactin and testosterone levels were measured both basally and after administration of LH-releasing hormone (LHRH) or human chorionic gonadotrophin (hCG) by means of specific radioimmunoassay systems using materials supplied by the NIADDK. After acute treatment with TP there was an increase in basal plasma testosterone concentrations and no modification in the hCG response when compared with vehicle-treated animals. No difference could be detected in basal plasma testosterone levels after the chronic treatment, but a significant reduction in the hCG response was observed. Both acute and chronic treatments with TP resulted in a significant decrease of basal plasma LH levels. A reduced LH response to LHRH in acutely treated rats and no response in the chronically treated rats was detected. Plasma prolactin levels showed an increase after both acute and chronic treatments. To evaluate the possible role of the increased plasma prolactin levels on the above modifications during TP treatment, another group of animals was treated with TP and bromocriptine (dopamine agonist) simultaneously to avoid the increase in plasma prolactin levels. In this situation, neither basal plasma LH levels nor the response to LHRH were altered when compared to vehicle-treated rats; a normal testosterone response to hCG stimulation was observed in spite of the high basal plasma testosterone levels. All these observations suggest that increased prolactin levels may exert a modulatory role on the negative feedback effect of testosterone both at the testicular and central levels. J. Endocr. (1985) 105, 423–427

Sign in / Sign up

Export Citation Format

Share Document